Sum composition results

AbbreviationFormulaMassMain ClassSub Class
GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2C54H100N2O181064.697119Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2C56H104N2O181092.728419Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2C58H108N2O181120.759719Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2C60H112N2O181148.791019Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2C62H114N2O181174.806669Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2C62H116N2O181176.822320Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2C64H118N2O181202.837970Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2C64H120N2O181204.853620Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2C60H110N2O231226.749944Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2C62H114N2O231254.781245Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 34:1;O2C62H113N3O231267.776493Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2C64H118N2O231282.812545Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 36:1;O2C64H117N3O231295.807793Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2C66H122N2O231310.843845Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 38:1;O2C66H121N3O231323.839093Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2C68H124N2O231336.859495Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2C68H126N2O231338.875145Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 40:1;O2C68H125N3O231351.870393Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2C70H128N2O231364.890795Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2C70H130N2O231366.906445Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2C66H120N2O271372.807855Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 42:2;O2C70H127N3O231377.886043Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 42:1;O2C70H129N3O231379.901693Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2C66H120N2O281388.802770Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2C68H124N2O271400.839155Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 44:2;O2C72H131N3O231405.917343Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 44:1;O2C72H133N3O231407.932994Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2C68H124N2O281416.834070Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2C70H128N2O271428.870455Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2C68H123N3O281429.829318Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 34:1;O2C68H123N3O281429.829318Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2C68H123N3O281429.829318Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2C70H128N2O281444.865370Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2C72H132N2O271456.901755Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2C70H127N3O281457.860618Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 36:1;O2C70H127N3O281457.860618Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2C70H127N3O281457.860618Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2C72H132N2O281472.896670Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2C74H134N2O271482.917405Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2C74H136N2O271484.933055Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2C72H131N3O281485.891919Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 38:1;O2C72H131N3O281485.891919Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2C72H131N3O281485.891919Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2C74H134N2O281498.912320Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2C74H136N2O281500.927970Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2C76H138N2O271510.948705Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2C76H140N2O271512.964355Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2C74H135N3O281513.923219Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 40:1;O2C74H135N3O281513.923219Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2C74H135N3O281513.923219Neutral glycosphingolipids [SP05]GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503]

Showing page 1 of 3     Results:    1  2  3  Next     Showing results 1 to 50 of 128